<DOC>
	<DOCNO>NCT00532415</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy triamcinolone acetonide suspension use visualization structure back eye eye surgery .</brief_summary>
	<brief_title>Safety Efficacy Vitreous Delineating Agent During Vitrectomy</brief_title>
	<detailed_description />
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Patients plan undergo par plana vitrectomy good vision nonsurgery eye . Other protocoldefined inclusion criterion may apply . Patients 18 . Patients previous vitrectomy , elevate intraocular pressure ( IOP ) and/or history ocular inflammatory disease . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Vitrectomy</keyword>
	<keyword>Visualization</keyword>
</DOC>